Refrain Made Schedule I

NEW YORK, NY (July 9, 2009) - Attorney General Esteban C. Portillo today announced that, pending the results of an extensive investigation by the Drug Enforcement Administration (DEA) and Department of Health and Human Services (HHS), he was exerting the power granted to his office to temporary place the drug known as 'Refrain' on Schedule I. As per the Controlled Substances Act, drugs classified under Schedule I cannot be prescribed, the production of them are subject to strict production quotas for research purposes only, and they cannot be possessed or sold as a legal object anywhere within the United States.

This substance, street name 'Refrain', began to appear on the streets of New York City only in late July of this year, and no reports have yet surfaced of the drug appearing in other cities elsewhere in the United States. Highly physically and psychologically addictive, the distinctive flourescent blue liquid is generally sold in syringes, and is reputedly a powerful hallucinogen when taken by Evolved individuals. Those who do not possess the Suresh Linkage Complex are either unaffected or minorly affected, making it thus-far unique amongst street drugs and pharmecuticals in general.

An anonymous source within the DEA told the Times that he believed there may be a possible connection between this Evolved-only drug and the German biotechnology firm Pinehearst, who claimed recently to be developing a 'cure for the Suresh Linkage Complex' before the abrupt demolition and investigation of their Fort Lee, NJ facility by federal authorities in July.

Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License